Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Coureche Kaderbhai"'
Autor:
Sylvain Ladoire, Ariane Mamguem Kamga, Loick Galland, Isabelle Desmoulins, Didier Mayeur, Courèche Kaderbhai, Silvia Mihaelia Ilie, Audrey Hennequin, Clementine Jankowski, Juliette Albuisson, Sophie Nambot, Charles Coutant, Laurent Arnould, Manon Reda, Caroline Truntzer, Sandrine Dabakuyo
Publikováno v:
Breast, Vol 78, Iss , Pp 103789- (2024)
Background: The results of the OlympiA study led to the approval of a PARP inhibitor (olaparib) as adjuvant treatment for early breast cancer (eBC) at high risk of relapse in patients with a germline BRCA1/2 mutation (gBRCAm). However, the proportion
Externí odkaz:
https://doaj.org/article/b67a5194fa204825b8518e79deea3b8e
Autor:
Manon Réda, Anaïs Fouquier, Isabelle Desmoulins, Didier Mayeur, Courèche Kaderbhai, Silvia Ilie, Audrey Hennequin, Bruno Coudert, Aurélie Bertaut, Sylvain Ladoire
Publikováno v:
Breast, Vol 68, Iss , Pp 149-156 (2023)
Background: Taxanes are major drugs for metastatic breast cancer (MBC) treatment, and are generally well tolerated, making them attractive for therapeutic reintroduction (rechallenge) during metastatic course. In view of the paucity of current litera
Externí odkaz:
https://doaj.org/article/d2c8a36ac89a4f8b968b3b3f7d9ac24f
Autor:
Alexandre Le Marouille, Emma Petit, Courèche Kaderbhaï, Isabelle Desmoulins, Audrey Hennequin, Didier Mayeur, Jean-David Fumet, Sylvain Ladoire, Zoé Tharin, Siavoshe Ayati, Silvia Ilie, Bernard Royer, Antonin Schmitt
Publikováno v:
Pharmaceutics, Vol 13, Iss 10, p 1708 (2021)
Palbociclib is an oral CDK4/6 inhibitor indicated in HR+/HER2- advanced or metastatic breast cancer in combination with hormonotherapy. Its main toxicity is neutropenia. The aim of our study was to describe the kinetics of circulating neutrophils fro
Externí odkaz:
https://doaj.org/article/5646a4677cb04fe080a4b1126b7ca586
Autor:
Francois Ghiringhelli, Romain Boidot, Caroline Truntzer, Bertrand Routy, Philippe Joubert, Julie Lecuelle, Laure Favier, Cléa Fraisse, Aurélie Lagrange, Coureche Kaderbhai, Sandy Chevrier
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 3 (2022)
Background Endogenous retroviruses (ERVs) are highly expressed in various cancer types and are associated with increased innate immune response and better efficacy of antiprogrammed death-1/ligand-1 (anti-PD1/PD-L1)-directed immune checkpoint inhibit
Externí odkaz:
https://doaj.org/article/28eb9d9b877048be85b905e79ee79501
Autor:
Nicolas Girard, Eric Pichon, David Planchard, Didier Debieuvre, Radj Gervais, Gaëlle Chenuc, Pascale Dubray-Longeras, J. Otto, Eric Dansin, Hervé Lena, Anne Madroszyk, Maurice Pérol, Thomas Filleron, Xavier Quantin, Lise Bosquet, Gaëtane Simon, Coureche Kaderbhai, Sophie Cousin, Sandrine Hiret, Christelle Clément-Duchêne, Christos Chouaid, Roland Schott
Publikováno v:
Targeted Oncology. 16:801-811
In Europe, few data regarding the characteristics of EGFR exon 20 insertion (20ins) mutations in non-small cell lung cancer (NSCLC) are available. Using a large real-world cohort, we assessed the incidence, characteristics, and outcomes of patients w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e82c91f8481d2a802c3a8c5a4cc4f86
https://doi.org/10.1007/s11523-021-00848-9
https://doi.org/10.1007/s11523-021-00848-9
Autor:
Siavoshe Ayati, Antonin Schmitt, Alexandre Le Marouille, Bernard Royer, Audrey Hennequin, Emma Petit, Sylvain Ladoire, Coureche Kaderbhai, Jean-David Fumet, Didier Mayeur, Silvia Ilie, Zoé Tharin, Isabelle Desmoulins
Publikováno v:
Pharmaceutics
Volume 13
Issue 10
Pharmaceutics, Vol 13, Iss 1708, p 1708 (2021)
Volume 13
Issue 10
Pharmaceutics, Vol 13, Iss 1708, p 1708 (2021)
Palbociclib is an oral CDK4/6 inhibitor indicated in HR+/HER2- advanced or metastatic breast cancer in combination with hormonotherapy. Its main toxicity is neutropenia. The aim of our study was to describe the kinetics of circulating neutrophils fro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::afa59923fc5ed94a5bd196396bc37464
http://europepmc.org/articles/PMC8537267
http://europepmc.org/articles/PMC8537267
Autor:
Antonin Schmitt, Jean-David Fumet, Sivia Ilie, Siavoshe Ayati, Audrey Hennequin, Sylvain Ladoire, Coureche Kaderbhai, Didier Mayeur, Isabelle Desmoulins, Bernard Royer
Publikováno v:
Pharmaceuticals
Volume 14
Issue 3
Pharmaceuticals, Vol 14, Iss 181, p 181 (2021)
Volume 14
Issue 3
Pharmaceuticals, Vol 14, Iss 181, p 181 (2021)
Palbociclib is an oral cyclin-dependent kinase inhibitor that is used in combination with aromatase inhibitors in the treatment of postmenopausal women with metastatic breast cancer. Its metabolism profile is associated with an important interpatient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ae02eb52c99987375656b44e6671dd5
Autor:
Laurent Arnould, Julie Vincent, Elise Ballot, Vincent Goussot, Cléa Fraisse, Charles Coutant, Anne-Laure Simonet-Lamm, Jean-David Fumet, Emilie Redersdorff, Nathalie Bremaud, Siavoshe Ayati, Adele Cueff, François Ghiringhelli, Sylvie Zanetta, Caroline Truntzer, Silvia Ilie, Didier Mayeur, Roxana Hanu, Bruno Coudert, Alice Hervieu, Sylvain Ladoire, Aurélie Lagrange, Aurélie Bertaut, Nils Martin, Coureche Kaderbhai, Leila Bengrine-Lefevre, Irina Mazilu, Laure Favier, Isabelle Desmoulins, Rémi Palmier, Audrey Hennequin
Publikováno v:
European Journal of Cancer
Background In view of the potential gravity of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection for patients with cancer, epidemiological data are vital to assess virus circulation among patients and staff of cancer centres. We
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9248d9a7af26b5aacca2eac067ea2438
http://europepmc.org/articles/PMC7914029
http://europepmc.org/articles/PMC7914029
Autor:
Julie Lecuelle, Laure Favier, Cléa Fraisse, Aurélie Lagrange, Coureche Kaderbhai, Romain Boidot, Sandy Chevrier, Philippe Joubert, Bertrand Routy, Caroline Truntzer, Francois Ghiringhelli
Publikováno v:
Journal for ImmunoTherapy of Cancer. 10:e004241
BackgroundEndogenous retroviruses (ERVs) are highly expressed in various cancer types and are associated with increased innate immune response and better efficacy of antiprogrammed death-1/ligand-1 (anti-PD1/PD-L1)-directed immune checkpoint inhibito
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8ce3840d66193c2336b830fad59d5b35
https://doi.org/10.1136/jitc-2021-004241
https://doi.org/10.1136/jitc-2021-004241
Publikováno v:
Revue Francophone des Laboratoires. 2018:46-51
Resume Le carcinome bronchique est un probleme majeur de sante publique avec 1,8 million de nouveaux cas par an et represente la premiere cause de mortalite par cancer dans le monde. Dans ce travail, nous nous interessons uniquement aux carcinomes br
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1e9f59bb10e4170d5f745570596f987d
https://doi.org/10.1016/s1773-035x(18)30322-8
https://doi.org/10.1016/s1773-035x(18)30322-8